AnaptysBio Inc buy Guggenheim
Start price
18.12.25
/
50%
€40.20
Target price
18.12.26
-
Performance (%)
18.38%
Price
08:10
?
Summary
This prediction is currently active. The prediction currently has a performance of 18.38%. This prediction currently runs until 18.12.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| AnaptysBio Inc | 4.064% | 4.064% |
| iShares Core DAX® | 3,15 % | 1,50 % |
| iShares Nasdaq 100 | 7,43 % | -1,58 % |
| iShares Nikkei 225® | 8,57 % | -4,32 % |
| iShares S&P 500 | 4,58 % | 1,92 % |
Comments by Guggenheim for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio (NASDAQ:ANAB) had its "buy" rating reaffirmed by analysts at Guggenheim.
Ratings data for ANAB provided by MarketBeat